2016
Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy
Jawitz OK, Boffa DJ, Detterbeck FC, Wang Z, Kim AW. Estimating the Annual Incremental Cost of Several Complications Following Pulmonary Lobectomy. Seminars In Thoracic And Cardiovascular Surgery 2016, 28: 531-540. PMID: 28043473, DOI: 10.1053/j.semtcvs.2016.06.001.Peer-Reviewed Original ResearchConceptsAcute respiratory failureLength of hospitalizationPulmonary lobectomyHospital stayRespiratory failureMajor complicationsAir leakAnnual health care expendituresRetrospective cohort analysisNational Inpatient SampleLength of stayPostoperative air leaksUtilization Project databaseAnnual incremental costMultivariable quantile regression modelsAggregate national costHealth care expendituresHealth care qualityLarge national datasetCommon complicationVATS lobectomyCostly complicationInpatient SampleHospital costsClinical data
2015
Multimodality therapy for locally advanced thymomas: A propensity score–matched cohort study from the European Society of Thoracic Surgeons Database
Leuzzi G, Rocco G, Ruffini E, Sperduti I, Detterbeck F, Weder W, Venuta F, Van Raemdonck D, Thomas P, Facciolo F, Group E. Multimodality therapy for locally advanced thymomas: A propensity score–matched cohort study from the European Society of Thoracic Surgeons Database. Journal Of Thoracic And Cardiovascular Surgery 2015, 151: 47-57.e1. PMID: 26403869, DOI: 10.1016/j.jtcvs.2015.08.034.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAsiaChemotherapy, AdjuvantChildChi-Square DistributionDatabases, FactualDisease ProgressionDisease-Free SurvivalEuropeFemaleHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoadjuvant TherapyNeoplasm Recurrence, LocalNeoplasm StagingNorth AmericaPropensity ScoreProportional Hazards ModelsRadiotherapy, AdjuvantRetrospective StudiesRisk AssessmentRisk FactorsSocieties, MedicalThymectomyThymomaThymus NeoplasmsTime FactorsTreatment OutcomeTumor BurdenYoung AdultConceptsRelapse-free survivalAdvanced thymomaMultimodality therapyOverall survivalT classificationPropensity score-matched cohort studyMultivariate Cox proportional hazards modelPropensity score-matched analysisCox proportional hazards modelPathologic T classificationStage III thymomaThoracic Surgeons databaseSignificant survival advantageSpecific pathologic featuresStrong predictive factorProportional hazards modelInduction therapyAdjuvant therapyPT3 tumorsCohort studyIndependent predictorsPrognostic impactMultivariable analysisPathologic featuresPredictive factors